公告及新聞稿, 監管通知 | 2015-04-01

Directors’ Shareholding

London: Wednesday, 1 April 2015: Chi-Med received notifications on 1 April 2015 that the following Directors have purchased ordinary shares of US$1.00 each in Chi-Med (the “Shares”) as follows:-

Director	Date of purchase	Number of Shares purchased	Purchase price	Beneficial interest in Shares following purchases
	Date of purchase	Number of Shares purchased	Purchase price	Number of Shares	% of total issued share capital
Simon To (Executive Director and Chairman)	30 March 2015 1 April 2015	13,000 15,000	GBP13.00 GBP13.65	69,000	0.13%
Edith Shih (Non-executive Director and Company Secretary)	30 March 2015 1 April 2015	13,000 15,000	GBP13.00 GBP13.65	48,000	0.09%

Ends

Enquiries

Chi-Med
Telephone: +852 2121 8200
Christian Hogg, CEO

Panmure Gordon (UK) Limited
Telephone: +44 20 7886 2500
Richard Gray
Andrew Potts

Citigate Dewe Rogerson
Telephone: +44 20 7638 9571
Anthony Carlisle Mobile: +44 7973 611 888
David Dible Mobile: +44 7967 566 919

About Chi-Med
Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products. Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases. Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China. Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13). For more information, please visit: www.chi-med.com.